Nanoliposome (Nal) and nanoliposomal irinotecan (Nal–IRI) were prepared following freeze–thaw extrusion method [21 (link), 22 (link), 48 (link), 49 (link)]. Briefly, cholesterol, dipalmitoylphosphatidylcholine (DPPC), distearoyl-phosphatidylethanolamine-methoxy polyethylene glycol (DSPE-mPEG2000), distearoyl-glycerophosphoethanolamine-N-dibenzocyclooctyl polyethylene glycol (DSPE-mPEG2000-DBCO), and dioleoylglycerophosphoglycerol (DOPG; Avanti) were mixed at a molar ratio of 2.8:6:0.4:0.2:0.6. For selectivity and uptake studies, 0.1 mol% of dipalmitoylglycero-phosphoethanolamine-N-(lissamine Rhodamine B sulfonyl) (16:0 Liss Rhod PE) was added to the lipid film. The dried lipid film was hydrated with deionized water with or without irinotecan (3 mM) prior to freeze–thaw cycling (4°C –45 °C). Multi-laminar nanoliposomes were then extruded through polycarbonate membrane (Whatman; 0.1 μm) at 45 °C and dialyzed against PBS to remove free irinotecan. Zetasizer NanoZS (Malvern) determined the size and zeta potential of Nals. The concentration of irinotecan was determined using UV–Vis spectroscopy and the established molar extinction coefficients (Additional file 1: Table S3) [21 (link), 22 (link), 48 (link)].
Free full text: Click here